Ua hoʻāʻo ʻia nā kānana ea antimicrobial hou ma nā kaʻaahi e pepehi koke iā SARS-CoV-2 a me nā maʻi ʻē aʻe

Ma kahi noiʻi i paʻi ʻia ma ka puke moʻolelo Scientific Reports ma Malaki 9, 2022, ua hana ʻia ka hoʻāʻo koʻikoʻi i ka mālama antibacterial o nā kānana ea i uhi ʻia me ka fungicide kemika i kapa ʻia ʻo chlorhexidine digluconate (CHDG) a hoʻohālikelike ʻia me nā kānana "control" maʻamau.

I loko o ke keʻena hana, ua hoʻohui ʻia nā cell o ka SARS-CoV-2 strain o ka maʻi maʻi COVID-19 i ka ʻili o ka kānana mālama ʻia a me ka kānana hoʻomalu, a ua lawe ʻia nā ana i nā manawa no hoʻokahi hola. Ua hōʻike ʻia nā hopena ʻoiai ʻo ka hapa nui o nā maʻi i noho ma ka ʻili o ka kānana hoʻomalu no hoʻokahi hola, ua pepehi ʻia nā cell SARS-CoV-2 āpau ma ka kānana mālama ʻia i loko o 60 kekona. Ua ʻike pū ʻia nā hopena like i nā hoʻokolohua e hoʻāʻo ana i ka bacteria a me nā haʻi e hoʻoulu pinepine ai i nā maʻi kanaka, me Escherichia coli, Staphylococcus aureus, a me Candida albicans, e hōʻike ana e hiki i kēia ʻenehana hou ke pale maikaʻi i nā fungi a me ka bacteria.

I ka manawa like, i mea e hoʻoholo ai i ka maikaʻi o ka kānana i loko o ke kaiapuni maoli, ua hoʻokomo ʻia ka kānana mana a me ka kānana i hana ʻia i loko o ka ʻōnaehana hoʻomehana, ventilation, a me ka ea o ke kaʻa kaʻa. Ua hoʻokomo pālua ʻia kēia mau kānana ma luna o nā kaʻa ma ka laina kaʻaahi hoʻokahi no ʻekolu mahina, a laila wehe ʻia a lawe ʻia i nā mea noiʻi no ka nānā ʻana e helu i nā ʻāpana bacteria i koe ma nā kānana. Ua ʻike ka hoʻokolohua ʻoiai ma hope o ʻekolu mahina ma ke kaʻaahi, ʻaʻohe pathogens i ola ma ka kānana mālama ʻia.

Ua ʻike hou ʻia ka hoʻāʻo hou ʻana he paʻa loa ka kānana i hoʻoponopono ʻia a hiki ke mālama i kona ʻano a me kāna hana kānana i loko o kona ola.

ʻO kā mākou SAF/FAF mea hoʻomaʻamaʻa antibacterial ʻelua i hoʻokahi kānana he hana antibacterial maikaʻi a maikaʻi hoʻi. Welina mai e kūkākūkā a kūʻai!